Research puts dollar value on cancer survival

Research puts dollar value on cancer survival

New research led by the University of the Sunshine Coast has for the first time Estimate the health care costs of surviving Queenslanders cancers in the 20 years to 2016.

A team led by doctor Katharine Merollinilong term study Health Service expenses of more than 230,000 people between 2013 and 2016 that he had been diagnosed with a first primary malignancy from 1997 onwards.

“We found average Health Service cost per person each yearit was $15,890”, said Dr. Merollini, aHealth economics academic ofUniSC Y the Costa del Sol Health Institute.

Breaking this down by types of malignancies, tthe higher annual Health Servicecosts for person were for the bone marrow disease myeloma ($46,000), brain cancer ($30,300) Y liver cancer ($29.600).

“These figures counted all related health and medical services, hospitalizationsemergency admissions and prescription drugs in that period, both related Y unrelated to Cancestor

He is co-author of the Associate Professor Louisa Gordon of the QIMR Berghofer Institute of Medical Research, the university of queensland and go out, doctor yu Ho from Central queensland Hospital and Health Service and UQProfessor Joanne Aitken of the Q Cancer Councilueensland, and teacher QUT’s Michael Kimlin.

Professor Aitken of Cancer Council Queensland said: “Given the enormous cost of cancer to the health system and knowing that one-third of cancers are preventable, a strong and clear message from this research is the importance of greater investment in cancer prevention.”

doctor Merollini said that the cumulative average annual health spending in everybody cancer survivors in queensland Among 2013 Y 2016 was $3.66billion.

According to data, youThe highest costs were incurred by patients with a history of prostate ($538 million), brisket ($496millon) either colorectal ($476 millionillon) cancers.

“TheI know costs they were typically highest in the first year after diagnosis and decreased over time.

He said it was the first population-level investigation of the costs of health services in queensland cancer survivors beyond the initial years of treatment and including all age groups and health conditions.

“It reveals a huge impact on health services,” said Dr. Merollini said.

We hope that the results Will report planning for policymakers in Australia, provide data for economic evaluations and reinforce the benefits of investing in cancer prevention.

Fast facts on cancer survival:

  • Worldwide, there are 19.3 million new cases of cancer per year, and this is expected to rise to 28.4 million cases in 2040;

  • Ddifferent stages are described as acute (from diagnosis to treatment), chronic (ongoing), long-term/late survival (after five years after diagnosis) and cured (no disease);

  • In Australia in 2021there were an estimated 151,000 new cancer diagnoses, Y 1.1 million people to live with a cancer history;

  • Tthe fiveThe annual relative survival for all cancers collectively is 70%;

  • Ccancer treatment has oftenrelated long-term health and financial costs to patients and their familiesof the physical (What fatigue and cognitive problems)the psychosocial (What anxiety Y depression), requirein grams doctor in progress watch out;

  • The indirect burden of cancer includes lost productivity, carer time and revenue reduction, as well as intangible costs suchh as interrupt families and lifestyles.

Fast facts on research data:

  • All Queensland residents diagnosed with a primary malignancy (excluding basal cell and squamous cell carcinoma of the skin), between January 1997 and December 2015, were eligible for the to study;

  • Did does not include costs incurred for private health care provided without Medicare participation or funded by private health care sure;

  • Only 14 percent were under 45 years old. On 52 percent were male;

  • TThe most common types of cancer recorded were prostate cancer (17.6%), melanoma (17.5%), breast (16.2%), and colorectal cancer (11.5%). The mean age at diagnosis was 60.5 years;

  • The lowest median costs were recorded for people diagnosed with melanoma ($9,500) and thyroid cancer ($8,800).

/ Public statement. This source organization/author(s) material may be of a one-off nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s). view in full here.

Leave a Comment